| Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer. (NCT04277858) | Nader Sadeghi | 2018-08-14 |
| Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease (NCT03459079) | University of Florida | 2018-08-14 |
| Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Induction Therapy (NCT03435848) | BioSight Ltd. | 2018-08-14 |
| Sublingual Cannabidiol for Anxiety (NCT02548559) | Staci Gruber, Ph.D. | 2018-08-14 |
| SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy. (NCT03558191) | Jiangsu HengRui Medicine Co., Ltd. | 2018-08-14 |
| Evaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study) (NCT03633461) | Oyster Point Pharma, Inc. | 2018-08-14 |
| Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer (NCT03520842) | Stanford University | 2018-08-14 |
| Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis. (NCT04056039) | Hospital Central "Dr. Ignacio Morones Prieto" | 2018-08-14 |
| Identification of Non-responders to Levothyroxine Therapy (NCT03627611) | Oslo University Hospital | 2018-08-14 |
| Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer (NCT03572478) | University of Chicago | 2018-08-14 |
| Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls (NCT03675282) | Weill Medical College of Cornell University | 2018-08-14 |
| Ocular Tolerability of Voclosporin Ophthalmic Solution Versus Restasis® in Subjects With Dry Eye Disease (NCT03597139) | Aurinia Pharmaceuticals Inc. | 2018-08-13 |
| Intra-operative Application of HEMOPATCH to the Pancreatic Stump to Prevent Post-operative Pancreatic Fistula Following Distal Pancreatectomy (NCT03410914) | Sunnybrook Health Sciences Centre | 2018-08-13 |
| A Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma (NCT03323151) | PrECOG, LLC. | 2018-08-13 |
| A Trial of Ipatasertib in Combination With Atezolizumab (NCT03673787) | Institute of Cancer Research, United Kingdom | 2018-08-13 |
| Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia (NCT03504644) | ECOG-ACRIN Cancer Research Group | 2018-08-13 |
| Treatment of Steroid Refractory Gastro-intestinal Acute GVHD afteR AllogeneiC HSCT With fEcal Microbiota tranSfer (NCT03359980) | MaaT Pharma | 2018-08-13 |
| Osimertinib In EGFR Mutant Lung Cancer (NCT03586453) | Dana-Farber Cancer Institute | 2018-08-13 |
| Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma (NCT03600467) | St Vincent's Hospital, Sydney | 2018-08-13 |
| PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants (NCT03392467) | Medipost Co Ltd. | 2018-08-13 |
| Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor (NCT03663764) | Sun Yat-sen University | 2018-08-13 |
| A Study of Anti-PD-1 AK105 in Patients With Relapsed or Refractory Classic Hodgkin Lymphoma (NCT03722147) | Akeso | 2018-08-13 |
| Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS (NCT03417154) | Masonic Cancer Center, University of Minnesota | 2018-08-13 |
| Palbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial) (NCT03526250) | National Cancer Institute (NCI) | 2018-08-13 |
| A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma (NCT03635892) | Memorial Sloan Kettering Cancer Center | 2018-08-13 |
| Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread (NCT03547973) | Gilead Sciences | 2018-08-13 |
| Trial Assessing the Inhibitor of Programmed Cell Death Ligand 1 (PD-L1) Immune Checkpoint Atezolizumab (NCT03612791) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-08-13 |
| A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) (NCT03207347) | University of Florida | 2018-08-13 |
| Obstructive Sleep Apnea (OSA) Treated With a Potassium Channel Inhibitor (NCT03603678) | Bayer | 2018-08-13 |
| Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block (NCT05158647) | Abdelrady S Ibrahim, MD | 2018-08-12 |
| Prospective Study on the Efficacy and Safety of 2 Week or 3 Week Xelox Regimen for Adjuvant Chemotherapy in CRC (NCT03564912) | Zhejiang University | 2018-08-12 |
| Study of Early Nutritional Intervention During Concurrent Chemoradiotherapy for Local Advanced Non-small Cell Lung Cancer (NCT03673657) | Sun Yat-sen University | 2018-08-10 |
| Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer (NCT04561336) | University of Campania Luigi Vanvitelli | 2018-08-10 |
| Imaging With a PET Agent for Detection of Cancers of the Head and Neck (NCT03631017) | Memorial Sloan Kettering Cancer Center | 2018-08-10 |
| A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NCT03563716) | Genentech, Inc. | 2018-08-10 |
| Plasmodium Immunotherapy for Breast and Liver Cancers (NCT03474822) | CAS Lamvac Biotech Co., Ltd. | 2018-08-10 |
| Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma (NCT03702491) | Eastern Hepatobiliary Surgery Hospital | 2018-08-10 |
| Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer (NCT03563248) | Massachusetts General Hospital | 2018-08-10 |
| Ketamine for Treatment of MS Fatigue (NCT03500289) | Johns Hopkins University | 2018-08-10 |
| Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes (NCT03645421) | AstraZeneca | 2018-08-10 |
| A Randomized, Placebo-controlled Trial of Antroquinonol in Patients With Chronic Hepatitis B (NCT04112147) | Cheng-Chung Wei | 2018-08-10 |
| A Study to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del (NCT03625466) | Vertex Pharmaceuticals Incorporated | 2018-08-10 |
| An Extension Study of V203-AD Study to Evaluate the Safety, Tolerability, Immunogenicity, and Efficacy of UB-311 (NCT03531710) | United Neuroscience Ltd. | 2018-08-10 |
| CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001) (NCT03631576) | Fujian Medical University | 2018-08-10 |
| Fecal Microbiota Transplantation for Irritable Bowel Syndrome (NCT03613545) | Guangzhou First People's Hospital | 2018-08-10 |
| A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS) (NCT02991469) | Sanofi | 2018-08-09 |
| Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke (NCT03592745) | Northwell Health | 2018-08-09 |
| Belimumab Treatment of Emphysema Patients With Anti-GRP78 Autoantibodies (NCT03244059) | University of Alabama at Birmingham | 2018-08-09 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis (NCT03630939) | Escalier Biosciences B.V. | 2018-08-09 |
| Methylprednisolone After Split-course Chemoradiotherapy For Bulky Local Advanced None-small Cell Lung Cancer (NCT03661567) | Sun Yat-sen University | 2018-08-09 |
| Effects of Trunk Exercise on Trunk Control and Balance in Persons With Stroke (NCT04434443) | National Cheng Kung University | 2018-08-09 |
| Study of Thymosin α1 to Reduce Acute Pneumonia For Bulky None-small Cell Lung Cancer (NCT03659578) | Sun Yat-sen University | 2018-08-09 |
| Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus (NCT03312335) | Onur Boyman, MD | 2018-08-08 |
| Safety and Efficacy of P-188 NF in DMD Patients (NCT03558958) | Phrixus Pharmaceuticals, Inc. | 2018-08-08 |
| BrEPEM-LH-22017 for Older Patients With Untreated Hodgkin Lymphoma (HL) (NCT03576378) | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | 2018-08-08 |
| The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. (NCT03577704) | Shanghai Henlius Biotech | 2018-08-08 |
| Open-Label Study of AG10 in Patients with Cardiomyopathy (NCT03536767) | Eidos Therapeutics, a BridgeBio company | 2018-08-08 |
| Ambulatory Gynecologic Surgery: Finding the Optimal Opioid Prescription (NCT03588910) | Montefiore Medical Center | 2018-08-08 |
| Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma (NCT03376659) | Georgetown University | 2018-08-08 |
| CMP-001 in Combo With Nivolumab in Stage IIIB/C/D Melanoma Patients With Clinically Apparent Lymph Node Disease (NCT03618641) | Diwakar Davar | 2018-08-08 |
| Efficacy and Safety of SOM3355 in Huntington's Disease Chorea (NCT03575676) | SOM Innovation Biotech SA | 2018-08-08 |
| Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer (NCT03526432) | University of Oklahoma | 2018-08-08 |
| Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression (NCT03598868) | Seoul National University Hospital | 2018-08-08 |
| A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies (NCT03650452) | Takeda | 2018-08-08 |
| PRISM Study-Pruritus Relief Through Itch Scratch Modulation (NCT03497975) | Trevi Therapeutics | 2018-08-07 |
| A Randomized, Double-Blind, Single-Center Clinical Study on the Efficacy of Naltrexone Implant in Antagonizing Opioid Agonist Hydromorphone (NCT07014644) | Shenzhen Sciencare Medical Industries Co., Ltd. | 2018-08-07 |
| Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis (NCT03616821) | AstraZeneca | 2018-08-07 |
| Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL (NCT03580928) | Dana-Farber Cancer Institute | 2018-08-07 |
| Dual TORC1/TORC2 Inhibitor ATG-008 (CC-223) in HBV Positive Advanced Hepatocellular Carcinoma (HCC) Subjects (NCT03591965) | Antengene Therapeutics Limited | 2018-08-07 |
| Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI) (NCT03551691) | Children's Hospital of Philadelphia | 2018-08-07 |
| Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast Cancer (NCT03377101) | National Cancer Institute (NCI) | 2018-08-07 |
| Darunavir and Rilpivirine Interactions With Levonorgestrel Implant (NCT03589027) | Makerere University | 2018-08-07 |
| Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients (NCT03611010) | Cumberland Pharmaceuticals | 2018-08-07 |
| The Role of Nicotine Dose and Route of Delivery in Affecting Adoption of E-cigarettes and Reducing Exposure to Toxic Combustion Products (NCT03492463) | Duke University | 2018-08-06 |
| A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular Carcinoma (NCT03586973) | Takeda | 2018-08-06 |
| Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer (NCT03630120) | H. Lee Moffitt Cancer Center and Research Institute | 2018-08-06 |
| Postoperative aRCH With Cisplatin Versus aRCH With Cisplatin and Pembrolizumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT03480672) | University of Leipzig | 2018-08-06 |
| Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer (NCT03571633) | Centre Leon Berard | 2018-08-06 |
| PD-1 Antibody Expressing mesoCAR-T Cells for Mesothelin Positive Advanced Solid Tumor (NCT03615313) | Shanghai Cell Therapy Research Institute | 2018-08-06 |
| Intrathecal Paracetamol Before Spinal Anaesthesia With Chloroprocaine HCl 1% for Short Knee Procedures (NCT03428230) | Sintetica SA | 2018-08-06 |
| Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001 (NCT03625934) | Viravaxx AG | 2018-08-06 |
| Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy (NCT03208231) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-08-06 |
| Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies (NCT03637764) | Sanofi | 2018-08-06 |
| Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase (NCT03531320) | InnoPharmax Inc. | 2018-08-06 |
| A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) (NCT03644069) | ImmusanT, Inc. | 2018-08-06 |
| Effectiveness of Dapagliflozin for Weight Loss (NCT03968224) | Centro Medico Nacional Siglo XXI IMSS | 2018-08-04 |
| Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC (NCT03812770) | Sun Yat-sen University | 2018-08-04 |
| Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients (NCT03518203) | Children's Hospital Medical Center, Cincinnati | 2018-08-03 |
| Trial of Roflumilast in Asthma Management (TRIM) (NCT03532490) | Johns Hopkins University | 2018-08-03 |
| Radial Artery Vasodilation Heat Study (NCT03620383) | Oregon Health and Science University | 2018-08-03 |
| Ascertain the Optimal Starting Dose of Mircera Given Subcutaneously for Maintenance Treatment of Anemia in Pediatric Patients With Chronic Kidney Disease on Dialysis or Not Yet on Dialysis. (NCT03552393) | Hoffmann-La Roche | 2018-08-03 |
| Can Imagination Change Upsetting Memories of Trauma? (NCT03607630) | King's College London | 2018-08-03 |
| Treatment of Refractory/Relapsed Non-Hodgkin Lymphoma With TriCAR-T_CD19 (NCT03497533) | Timmune Biotech Inc. | 2018-08-03 |
| Long-term Follow-up of Patients Treated With Genetically Modified Autologous T Cells (NCT03628612) | Autolus Limited | 2018-08-02 |
| Ixazomib Maintenance Study in Patients With AL Amyloidosis (NCT03618537) | Memorial Sloan Kettering Cancer Center | 2018-08-02 |
| CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment (NCT05381662) | Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd | 2018-08-02 |
| T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias (NCT03653338) | Paul Szabolcs | 2018-08-02 |
| Prospective Study in Adults Evaluating Safety & Efficacy of NVD003 for Bone Reconstruction to Treat Lower Limb Nonunion (NCT06335394) | Novadip Biosciences | 2018-08-02 |
| Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery (NCT03541928) | The Methodist Hospital Research Institute | 2018-08-02 |
| A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder (NCT03519256) | Bristol-Myers Squibb | 2018-08-02 |